Expression and preliminary bioactivity analysis of the recombinant Staphylococcus aureus enterotoxin C3
LI Xian-Ping,WANG Min,WU Ting,MEI Cheng,CAO Hong
DOI: https://doi.org/10.3969/j.issn.1000-484X.2012.07.003
2012-01-01
Abstract:Objective:To express the recombinant Staphylococcus aureus enterotoxin C3(rSEC3) and preliminary investigate its activity.Methods:E.coli BL21 containing the recombinant plasmids pET-32a(+)-SEC3 was expressed and purified.Then the human PBMCs was stimulated with different concentration of rSEC3 at 0.1,0.5,1,5,10,50,100 μg/ml and the promoting proliferation activity was detected by MTT method.Last,the tumor-cytotoxicity effects of Hela and KYSE were examined after being induced 48 h.Results:The recombinant Staphylococcus aureus enterotoxin C3 was expressed efficiently in E.coli BL21.Compared with blank control,0.1-100 μg/ml of rSEC3 could significantly promote proliferation of human PBMCs(P<0.05).1 μg/ml of rSEC3 was the most efficient dose(t=113.851,P=0.000) and showed a similar effect with 100 μg/ml PHA(t=0.693,P=0.527).After cultured 48 h,rSEC3 at 0.5,1,5 μg/ml had a strong depressant effect on Hela by activating PBMC compared with blank control(P<0.05).The inhibition rates were(70.44±9.27)%,(93.65±8.05)%,and(103.40±6.65)%.Furthermore,the rSEC3 also enhanced the killing activity to KYSE cells(P<0.05),and the inhibition rates were(28.10±2.72)%,(46.62±4.17)%,and(19.35±3.05)%,respectively.Conclusion:The recombinant protein rSEC3 has activity on human PBMCs proliferation,and it can enhance PBMCs killing effect on tumor cells.